75000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Consolidated Statements of Operations and Comprehensive Loss 2 link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 75060 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 75070 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance link:presentationLink link:calculationLink link:definitionLink 995457 - Disclosure - Nature of Business link:presentationLink link:calculationLink link:definitionLink 995467 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995477 - Disclosure - Supplemental Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 995487 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 995497 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995507 - Disclosure - Equipment and Improvements link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - Acquisition of CorHepta link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - Insurance Premium Financing Payable link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - ABLi License Agreement link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995557 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 995567 - Disclosure - ATM Program link:presentationLink link:calculationLink link:definitionLink 995577 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 995587 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 995597 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995607 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995617 - Disclosure - Simple Retirement Account for Employees (the "Simple IRA") link:presentationLink link:calculationLink link:definitionLink 995627 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995637 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995647 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995657 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995667 - Disclosure - Supplemental Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995677 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995687 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 995697 - Disclosure - Equipment and Improvements (Tables) link:presentationLink link:calculationLink link:definitionLink 995707 - Disclosure - Acquisition of CorHepta (Tables) link:presentationLink link:calculationLink link:definitionLink 995717 - Disclosure - Insurance Premium Financing Payable (Table) link:presentationLink link:calculationLink link:definitionLink 995727 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995737 - Disclosure - Net Loss Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 995747 - Disclosure - Income Taxes (Table) link:presentationLink link:calculationLink link:definitionLink 995757 - Disclosure - Commitments and Contingencies (Table) link:presentationLink link:calculationLink link:definitionLink 995767 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995777 - Disclosure - Nature of Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995787 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:calculationLink link:definitionLink 995797 - Disclosure - Summary of Significant Accounting Policies - Schedule ofEquipment and Improvements (Details) link:presentationLink link:calculationLink link:definitionLink 995807 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Detail) link:presentationLink link:calculationLink link:definitionLink 995817 - Disclosure - Fair Value of Financial Instruments - Summery of cash equivalents and marketable securities measured at their fair value on a recurring basis as (Details) link:presentationLink link:calculationLink link:definitionLink 995827 - Disclosure - Fair Value of Financial Instruments - Summary of Contingent Consideration Related to Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 995837 - Disclosure - Marketable Securities - Summary of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995847 - Disclosure - Marketable Securities (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995857 - Disclosure - Equipment and Improvements - Schedule Of Equipment and Improvements, net (Details) link:presentationLink link:calculationLink link:definitionLink 995867 - Disclosure - Acquisition of CorHepta - Schedule of fair value of consideration transferred (Details) link:presentationLink link:calculationLink link:definitionLink 995877 - Disclosure - Acquisition of CorHepta - Schedule of Allocation of Consideration Transferred (Details) link:presentationLink link:calculationLink link:definitionLink 995887 - Disclosure - Acquisition of CorHepta (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995897 - Disclosure - ABLi License Agreement (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995907 - Disclosure - Equipment and Improvements (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 995917 - Disclosure - Insurance Premium Financing Payable - Summary of Insurance Premium Financing Payable (Details) link:presentationLink link:calculationLink link:definitionLink 995927 - Disclosure - Insurance Premium Financing Payable - Summary of Future Principal Payments on Insurance Premium Financing Payable (Details) link:presentationLink link:calculationLink link:definitionLink 995937 - Disclosure - Insurance Premium Financing Payable - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995947 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995957 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995967 - Disclosure - Stock-Based Compensation - Summary of Option Activity Under 2011 Plan and 2020 Plan (Details) link:presentationLink link:calculationLink link:definitionLink 995977 - Disclosure - Stock-Based Compensation - Summary of Option Activity Under 2011 Plan and 2020 Plan (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995987 - Disclosure - Stock-Based Compensation - Summary of Estimated Assumptions of Weighted-Average Fair Values of Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 995997 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Details) link:presentationLink link:calculationLink link:definitionLink 996007 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996017 - Disclosure - ATM Program (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996027 - Disclosure - Warrants - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996037 - Disclosure - Net Loss Per Share (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink 996047 - Disclosure - Net Loss Per Share - Summary of Calculation of Basic and Diluted Net Loss Per Share applicable to Common Stockholders (Detail) link:presentationLink link:calculationLink link:definitionLink 996057 - Disclosure - Net Loss Per Share - Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders (Detail) link:presentationLink link:calculationLink link:definitionLink 996067 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996077 - Disclosure - Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 996087 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996097 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996107 - Disclosure - Commitments and Contingencies - Summary of Future minimum lease payments (Details) link:presentationLink link:calculationLink link:definitionLink 996117 - Disclosure - Commitments and Contingencies - Schedule of Milestone Payment (Details) link:presentationLink link:calculationLink link:definitionLink 996127 - Disclosure - Simple Retirement Account for Employees (the "Simple IRA") - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996137 - Disclosure - Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Details) link:presentationLink link:calculationLink link:definitionLink 996147 - Disclosure - Segment Information - Schedule of financial information regularly reviewed and used by the CODM (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 996157 - Disclosure - Subsequent Events - (Additional Information) (Details) link:presentationLink link:calculationLink link:definitionLink Operating Lease Period Operating Lease Period Operating Lease Period Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Shares Unvested Shares Unvested On Acquisition Shares Unvested On Acquisition Underwriters Underwriters [Member] Underwriters. Deferred Compensation Arrangement with Individual, Exercise Price Stock option granted, exercise price Deferred Tax Assets Accrued Expenses Deferred Tax Assets Accrued Expenses Accrued expenses Other Research and Development Expense Other research and development Lessor, Operating Lease, Description Lessor, Operating Lease, Description Concentration Risk Type [Axis] Concentration Risk Type Performance Based forfeited Shares Performance Based forfeited Shares Performance Based forfeited Shares Entity Incorporation, State or Country Code Preferred Stock, Shares Issued, Total Preferred Stock, Shares Issued Preferred stock, shares issued Statement of Financial Position Location, Balance [Domain] Effective Income Tax Rate Reconciliation, Tax Credit, Amount [Abstract] Tax Credits: Increase (Decrease) in Accounts Payable, Total Increase (Decrease) in Accounts Payable Accounts payable Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Non-cash investing and financing activities Plan Name [Axis] Plan Name Research and Development Expense [Abstract] Research and development (excluding share-based compensation) expense: Entity Current Reporting Status Fair Value, Inputs, Level 2 [Member] Level 2 Deferred Tax Assets, Net of Valuation Allowance Net deferred tax asset (liability) Warrants to purchase shares of stock. Warrants To Purchase Shares Of Stock [Member] Warrants to Purchase Shares of Stock Common Stock, Shares Authorized Common stock, shares authorized Asset Acquisitions Asset Retirement Obligation [Policy Text Block] Product and Service [Axis] Product and Service Document Fiscal Period Focus Debt Instrument, Interest Rate, Stated Percentage Annual interest rate Entity Shell Company Other Accrued Liabilities, Current Accrued other Segment Reporting, Policy [Policy Text Block] Segment Information Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalent Cash and cash equivalents Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type Summary of significant accounting policies. Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Stock Issued During Period, Shares, Conversion of Units Conversion of notes, Shares Cybersecurity Risk Management, Strategy, and Governance [Abstract] Common Shares Sold Common Stock, Shares, Issued, Total Common Stock, Shares, Issued Common stock, shares issued Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Cybersecurity Risk Board of Directors Oversight [Text Block] Lessee, Operating Lease, Description Operating leases description Fixed Assets Fixed Assets Deferred Tax Liabilities, Other Finite-Lived Assets Statement [Table] Statement [Table] Service and performance based vesting shares Service And Performance Based Vesting Shares Service And Performance Based Vesting Shares Insurance premium financing payable Insurance Premium Financing Payable Insurance Premium Financing Payable 2019 CFO Note Two thousand and nineteen note CFO. Two Thousand And Nineteen Note C F O [Member] Placement Agent Warrants [Member] Placement Agent Warrants [Member] Placement Agent Warrants [Member] Placement Agent Warrants Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Options, Grants in Period, Weighted Average Fair Value Percentage of Common Stock Outstanding Percentage of Common Stock Outstanding, During Period Increase (Decrease) Percentage of Common Stock Outstanding, During Period Increase (Decrease) Statement [Line Items] Statement [Line Items] Business Combination [Domain] Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Weighted Average Exercise Price ,Cancelled Warrant [Member] Warrant [Member] Entity Filer Category Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Indefinite-Lived Acquired IPR&D Total liabilities and stockholders' equity Liabilities and Equity Business Combination, Recognized Liability Assumed, Liability, Current Business Combination, Recognized Liability Assumed, Liability, Current, Total Current liabilities Debt Instrument [Line Items] Debt Instrument [Line Items] Issuance of common stock, stock options exercised Stock Issued, Value, Stock Options Exercised, Net of Tax Benefit (Expense) Payments to Acquire Marketable Securities Purchases of investments - marketable securities Purchases of investments - marketable securities 2026 Long-Term Debt, Maturity, Year Three Weighted Average Exercise Price, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Long-Lived Tangible Asset [Axis] Lease obligation payable monthly installments Debt Instrument, Frequency of Periodic Payment Deferred tax asset, increase in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Accrued consulting current. Accrued Consulting Current Accrued consulting Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses And Other Current Assets Member Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents and marketable securities measured at their fair value on a recurring basis Cash equivalents Deferred Tax Assets, Valuation Allowance, Total Deferred Tax Assets, Valuation Allowance Deferred tax asset valuation allowance US Federal Statutory Tax Rate, Percentage Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Shares Issued, Price Per Share Shares issued price per share Subsequent Event [Line Items] Cybersecurity Risk Management Third Party Engaged [Flag] Documents Incorporated by Reference [Text Block] Documents Incorporated by Reference Total Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Percent FDA Approval FDA Approval. F D A Approval [Member] Income Tax Jurisdiction [Axis] Income Tax Authority Increase Decrease In Operating Lease Liabilities. Increase Decrease In Operating Lease Liabilities Operating lease liabilities License termination date Termination Date Of License Agreement Termination date Of license agreement Additional Paid in Capital, Common Stock, Ending Balance Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock Additional paid-in capital License A. License A [Member] License A Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Property, Plant and Equipment [Line Items] Agreement ended date description Debt Instrument, Maturity Date, Description Maturity description Increased in base salary Deferred Compensation Arrangement with Individual, Compensation Expense Annual base salary Vesting [Domain] Vesting Number of options vest purchase Number of Shares, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Cybersecurity Risk Management, Strategy, and Governance [Table] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of Calculation of Basic and Diluted Net Loss Per Share applicable to Common Stockholders Description of Warrants And Rights Outstanding Term Description of Warrants And Rights Outstanding Term Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract] Nontaxable or Nondeductible Items: Notes Payable AON [Member] Notes Payable A O N [Member] Notes payable aon. Earnings Per Share, Basic Net loss per share applicable to common stockholders - basic Net loss per share - basic Retirement Benefits [Text Block] Simple Retirement Account for Employees (the "Simple IRA") Number of Shares Outstanding, Beginning Balance Number of Shares Outstanding, Ending Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Schedule of Estimated Assumptions of Weighted-Average Fair Values of Options Granted Other Liabilities, Fair Value Disclosure Other current liabilities Increase in target bonus, percentage Deferred Compensation Arrangement with Individual, Cash Awards Granted, Percentage Percentage of annual base salary Liabilities, Current Total current liabilities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Domestic Tax Jurisdiction [Member] Domestic Tax Authority Effective Income Tax Rate Reconciliation, Tax Credit, Percent [Abstract] Tax Credits, Percentage: Contingently Issuable Common Stock Subject To Vesting Criteria, Value Contingently Issuable Common Stock Subject To Vesting Criteria, Value Contingently Issuable Common Stock Subject To Vesting Criteria, Value Consolidation Items [Domain] Stockholders' equity: Equity, Attributable to Parent [Abstract] Two thousand and nineteen note. Two Thousand And Nineteen Note [Member] 2019 Note Entity Small Business Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms Plan modification Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Accumulated deficit Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Stock-based compensation Nature of Operations [Text Block] Nature of Business Entity Well-known Seasoned Issuer Individual retirement plan, coverage requirement, minimum compensation amount reasonably expected to received Individual Retirement Plan Coverage Requirement Minimum Compensation Amount Reasonably Expected To Received Individual retirement plan, coverage requirement, minimum compensation amount reasonably expected to received Number of Shares, Forfeited Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period CFO Note C F O Note [Member] C F O Note [Member] License termination cost License Agreement Termination Cost License agreement termination cost Proceeds from Issuance Initial Public Offering Proceeds from issuance of common stock from public offerings, net of issuance costs Frattaroli Employment Agreement Frattaroli Employment Agreement [Member] Frattaroli Employment Agreement Sale of common stock per Share Sale of Stock, Price Per Share Common stock price to public Common stock Aggregate offering price Common stock Aggregate offering price Common stock Aggregate offering price Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] CorHepta Pharmaceuticals [Member] CorHepta Pharmaceuticals [Member] CorHepta Pharmaceuticals [Member] Armistice Capital Master Fund Ltd [Member] Armistice Capital Master Fund Ltd [Member] Armistice Capital Master Fund Ltd [Member] Deferred Compensation Arrangement with Individual, Shares Issued Stock option granted Organization Consolidation And Presentation [Table] Organization Consolidation And Presentation [Table] Organization Consolidation And Presentation [Table] Amendment Amendment Flag Product and Service [Domain] Product and Service Loss Contingencies [Line Items] Loss Contingencies [Line Items] Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount US Federal Statutory Tax Rate, Amount Class of Warrant or Right, Date from which Warrants or Rights Exercisable Class of warrant or right, date from which warrants or rights exercisable Purchase of Common Warrants in Conversion of Common Stock Class of warrant or right number of securities called by warrants or rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share Mark Iwicki [Member] Mark Iwicki [Member] Mark Iwicki [Member] Liabilities and stockholders' equity Liabilities and Equity [Abstract] Entity Address, Postal Zip Code Accounts Receivable [Policy Text Block] Accounts receivable Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Working capital Working capital Working Capital Working capital. Contigent payment of performance milestones Contigent Payment of Performance Milestones Contigent Payment of Performance Milestones Common Stock Common Stock [Member] Common Stock [Member] Cybersecurity Risk Role of Management [Text Block] 2024 Long-Term Debt, Maturity, Year One Weighted Average Exercise Price ,Granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Shares representing post-merger compensation expense Shares Representing Post-Merger Compensation Expense Shares Representing Post-Merger Compensation Expense Common stock per share entitled to vote. Common Stock Per Share Entitled To Vote Votes per each common stock share Estimated total remaining contract costs Estimated Remaining Contract Costs Estimated Remaining Contract Costs Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type Entity Address, Address Line One Total deferred tax asset Total deferred tax assets Deferred Tax Liabilities, Gross Organization Consolidation And Presentation [Line Items] Organization Consolidation And Presentation [Line Items] Organization Consolidation And Presentation [Line Items] Marketable Securities [Table] Two Thousand And Eighteen Flagship Note Two Thousand And Eighteen Flagship Note [Member] 2018 Flagship Note Fair Value Hierarchy and NAV [Axis] Earnings Per Share [Abstract] Income Tax, Policy [Policy Text Block] Income Taxes Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Supplemental Cash Flow Information [Abstract] Supplemental disclosures of cash flow information Total incremental fair value expense recognized Total incremental fair value expense recognized Statement of Financial Position Location, Balance [Axis] Operating Lease, Right-of-Use Asset Right-of-use asset Operating lease right-of-use assets Offering costs, underwriting discounts and commissions. Offering Costs Underwriting Discounts And Commissions Offering costs, underwriting discounts and commissions Deferred Tax Assets, Gross Total deferred tax assets before valuation allowance Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Class of Warrant or Right [Axis] Document Type Document Type 2011 and 2020 Plan Two Thousand And Eleven Plan And Two Thousand And Twenty Plan [Member] 2011 Plan and 2020 Plan 2020 plan. Two Thousand And Twenty Plan [Member] 2020 Plan Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Schedule of Milestone Payment Schedule Of Milestone Payments [Table Text Block] Schedule of milestone payments. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Inhibikase Therapeutics 401(k) Plan [Member] Inhibikase Therapeutics 401(k) Plan [Member] Inhibikase Therapeutics 401(k) Plan [Member] CIK Entity Central Index Key Marketable securities, obligations maturity period Marketable Securities, Obligations Maturity Period Marketable Securities, Obligations Maturity Period Investments, Debt and Equity Securities [Abstract] Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Lease obligation lease Obligation lease obligation. Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Net increase in cash and cash equivalents Subsequent Event Type [Domain] Issuance of warrants Fair Value Adjustment of Warrants Initial fair value of Warrants Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total Armistice Capital Master Fund Ltd [Member] Armistice [Member] Armistice [Member] Common Stock, Par or Stated Value Per Share Common stock, par value Security Deposit Lease Security Deposit Clinical Research Study Clinical Research Study Clinical Research Study Proceeds from Issuance of Warrants warrant issued Weighted Average Remaining Contractual Term (In Years), Outstanding Ending Balance Weighted Average Remaining Contractual Term (In Years), Outstanding Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Asset Acquisition, Contingent Consideration, Liability Asset Acquisition, Contingent Consideration, Liability, Total Contingent consideration Debt Securities, Available-for-Sale, Amortized Cost Marketable securities, Amortized cost Marketable securities, Amortized cost Marketable securities, available-for-sale Consulting Services Consulting Services [Member] Consulting services. Issuance of common stock, stock options exercised, Shares Issuance of common stock, stock options exercised Issuance of common stock, stock options exercised Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Securities Purchase Agreement 1 [Member] Non Cash Financing Contingent Consideration Non Cash Financing Contingent Consideration Contingent consideration Document Financial Statement Error Correction [Flag] Number of Shares, Exercised Number of Shares, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Issuance of common stock, stock options exercised, Shares Debt Disclosure [Abstract] Collaboration Agreement Fixed Minimum Payments. Collaboration Agreement Fixed Minimum Payments License agreement, fixed fee paid Marketable Securities Marketable securities, Fair Value Marketable securities Accrued Liabilities, Current Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Restricted Stock Awards Issued Stock Issued During Period, Value, Restricted Stock Award, Gross Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Current Fiscal Year End Date Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Table] Accrued compensation Other Accrued Liabilities Entity Address, State or Province Restricted stock units outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Beginning Balance Asset Acquisition [Domain] Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Preferred stock, shares outstanding October 2024 Offering [Member] October Two Thousand Twenty Four Offering [Member] October Two Thousand Twenty Four Offering [Member] Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Common Stock, Capital Shares Reserved for Future Issuance Common stock shares reserved for issuance Class of Warrant or Right [Domain] Business Combination, Transaction Cost, Excluding Separately Recognized Transaction Transaction costs incurred by the Company Marketable Securities, Current Marketable securities Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Summary of Stock-Based Compensation Expense for Stock Options Granted to Employees and Non-Employees Other, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount Professional Fees Consulting services fee per month Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock, stock options exercised Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Components of Deferred Tax Assets and Liabilities ABLi License Agreement Collaborative Arrangement Disclosure [Text Block] Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive income (loss), net of tax Proceeds from Sale and Maturity of Marketable Securities Proceeds from maturities of marketable securities Subsequent Event [Member] Subsequent Event Marketable Securities, Policy [Policy Text Block] Marketable Securities Paycheck Protection Program Paycheck protection program. Paycheck Protection Program [Member] Operating loss carryforwards expiration year Operating Loss Carryforwards Expiration Year Operating Loss Carryforwards Expiration Year First Anniversary Date Of Grant [Member] First Anniversary Date Of Grant [Member] First Anniversary Date Of Grant Property, Plant and Equipment [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of additional shares authorized Other Assets, Noncurrent Amount held as a retainer Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Antidilutive Securities [Axis] Antidilutive Securities Number of Shares, Cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Number of Shares, Cancelled State and Local Jurisdiction [Member] State [Member] Related Party Transaction [Axis] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income (Loss) Individual retirement plan, coverage requirement, minimum compensation amount received during two preceding years Individual Retirement Plan Coverage Requirement Minimum Compensation Amount Received During Two Preceding Years Individual retirement plan, coverage requirement, minimum compensation amount received during two preceding years 2011 Equity Incentive Plan [Member] Two Thousand Eleven Equity Incentive Plan [Member] Two thousand eleven equity incentive plan. Cash and Cash Equivalents [Domain] Asset Acquisition, Contingent Consideration [Table Text Block] Summary of Contingent Consideration Related to Acquisition Business Combination, Consideration Transferred Fair value of consideration Consideration transferred Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Preferred Stock, Value, Issued Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2025 and December 31, 2024 non-cash exercise option Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable, Ending Balance Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable, Beginning Balance Selling, General and Administrative Expense, Total Selling, General and Administrative Expense Selling, general and administrative Class Of Warrant Or Right Common Stock Shares Conversion Percentage Class of warrant or right common stock shares conversion percentage. Class of warrant or right issued, percentage Minimum [Member] Minimum [Member] Financial Instrument [Axis] Assets, Current [Abstract] Current assets: Other Comprehensive Income (Loss), Tax, Total Other Comprehensive Income (Loss), Tax Other comprehensive income Fair Value, Inputs, Level 3 [Member] Level 3 Segment Reporting [Abstract] Wainwright Agreement [Member] Wainwright Agreement [Member] Wainwright Agreement Fair Value, Assets Measured on Recurring Basis [Table Text Block] Summery of Fair Value Assets Measured On Recurring Basis Liabilities, Current [Abstract] Current liabilities: Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition Costs, Percent Acquisition costs, Percentage Net operating loss carryforwards Operating Loss Carryforwards, Total Operating Loss Carryforwards Accrued research and development current. Accrued Research And Development Current Accrued research and development Prepaid research and development, noncurrent Prepaid Expense, Noncurrent Prepaid Expense, Noncurrent, Total Christopher Cabell, M.D. [Member] Christopher Cabell, M.D. [Member] Christopher Cabell, M.D. [Member] Total potential milestone payments Total potential milestone payments. Potential Milestone Payment Amount Commitments and Contingencies Commitments and contingencies (see Note 15) Lessee, Leases [Policy Text Block] Leases Operating Lease, Liability, Total Operating Lease, Liability Present value of operating lease liabilities Operating lease liabilities Operating lease liabilities Auditor Firm ID Reverse stock split description Stockholders' Equity, Reverse Stock Split Reverse stock split description Forecast [Member] Forecast [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark Vendor [Member] Vendor [Member] Vendor. Revenue From Contract With Customer Product And Service Extensible List Revenue from Contract with Customer, Product and Service [Extensible Enumeration] 2025 Long-Term Debt, Maturity, Year Two Issued and sold fully paid non-assessable shares of common stock. Issued And Sold Fully Paid Non Assessable Shares Of Common Stock Issued and sold fully paid non-assessable shares of common stock 2020 Note Two thousand and twenty note. Two Thousand And Twenty Note [Member] 2020 Equity Incentive Plan [Member] Two Thousand Twenty Equity Incentive Plan [Member] Two thousand twenty equity incentive plan. CEO Restated Note Ceo restated note. C E O Restated Note [Member] CEO Restated Note Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance, Percentage Allowance for Doubtful Accounts, Premiums and Other Receivables Allowance for doubtful accounts Interest income Interest Income (Expense), Net, Total Interest Income (Expense), Operating Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent Cash Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Loss Contingencies [Table] Loss Contingencies [Table] Weighted Average Number of Shares Outstanding, Basic Weighted-average number of common shares outstanding - basic Weighted-average number of shares_basic Cash, cash equivalents and marketable securities Cash Equivalents And Marketable Securities Cash Equivalents and Marketable Securities Scenario [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Reconciliation of Effective Income Tax Rate Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Long-Lived Tangible Asset [Domain] Liquidity and going concern. Liquidity And Going Concern [Text Block] Liquidity and Going Concern Liquidity Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Sphaera Pharma Pte. Ltd. [Member] Sphaera Pharma Pte. Ltd. [Member] Net proceeds from agent (Private Placement) Proceeds from Issuance of Private Placement Subsequent Events Subsequent Events [Text Block] Long-Term Debt Total notes payable Cash Cash, Ending Balance Cash, Beginning Balance Cash Cash and cash equivalents APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Sales Agreement [Member] Sales Agreement [Member] Sales Agreement [Member] Written off As Research And Development Expense Written off As Research And Development Expense Written off Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Change in valuation allowance, Amount Equity, Attributable to Parent Ending balance Beginning balance Total stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Effective Income Tax Rate Reconciliation, Limitation on tax attributes, Research, Percent Effective Income Tax Rate Reconciliation, Limitation on tax attributes, Research, Percent Limitation on tax attributes, Percentage Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Escrow Share [Member] Escrow Share [Member] Escrow Share Statement of Stockholders' Equity [Abstract] Series C Preferred Stock [Member] Series C Preferred Stock [Member] Duke University License Agreement. Duke University License Agreement [Member] Duke University License Agreement Series A Preferred Stock [Member] Series A Preferred Stock [Member] Use of Estimates, Policy [Policy Text Block] Use of Estimates 2028 Long-Term Debt, Maturity, Year Five Leaseholds and Leasehold Improvements [Member] Leasehold property improvements, right of use assets Defined Benefit Plan Disclosure [Line Items] Over-Allotment Option [Member] June 2021 Offering Entity Address, Address Line Two Write-off of in-process research and development Write Off of In Process Research and Development Write Off of In Process Research and Development Fair Value Disclosures [Text Block] Fair Value of Financial Instruments License B [Member] License B. Warrants and Rights Note Disclosure [Abstract] Securities Purchase Agreements [Member] Securities Purchase Agreements [Member] Securities Purchase Agreements [Member] Debt Instrument, Name [Domain] Debt Instrument, Name CorHepta [Member] CorHepta [Member] CorHepta [Member] 2027 Long-Term Debt, Maturity, Year Four Prepaid Expense and Other Assets Upfront Payment Piper Sandler & Co. as sales agent [Member] Piper Sandler & Co. as sales agent [Member] Piper Sandler & Co. as sales agent In Process Research and Development [Member] In Process Research and Development Plan Name [Domain] Plan Name Increase (Decrease) in Other Operating Assets Increase (Decrease) in Other Operating Assets, Total Other assets Deferred Compensation Arrangement with Individual, Contributions by Employer Compensation contributions under simple IRA Increase Decrease Transition Payment Amount Increase Decrease Transition Payment Amount Increasing the total contracted amount Cost of Product and Service Sold Cost of Goods and Services Sold, Total Net sales of FDA approved drug Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Issuance of common stock, pre-funded warrants and warrants, net of issuance costs Stock Issued During Period, Value, Other Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Class of Warrant or Right, Outstanding Warrants outstanding Treasury share held Treasury Stock, Value Treasury Stock, Value, Ending Balance Treasury Stock, Value, Beginning Balance Treasury Stock, Value, Total Deferred Compensation Arrangement with Individual, Requisite Service Period Stock option granted, vesting period Related and Nonrelated Parties [Axis] Class of Warrant or Right [Table] Class Of Warrant Or Right [Table] Foreign Tax Jurisdiction [Member] Foreign Tax Authority Property, Plant and Equipment, Policy [Policy Text Block] Equipment and Improvements Entity Address, City or Town Security Exchange Name Payment Related To Acquisition Payment Related To Acquisition Payments Increase (decrease) in prepaid research and development. Increase Decrease In Prepaid Research And Development Prepaid research and development Date of acquisition agreement Business Combination, Date of Acquisition Agreement Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross Property, Plant and Equipment, Gross Debt Securities, Available-for-Sale, Unrealized Gain (Loss) Marketable securities, Unrealized Gain Marketable securities, UnrealizedLoss License Agreement Term. License Agreement Term License agreement, term Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total Pretax Income (Loss) Number of Shares , Vested or Expected To Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Concentration Risk Type [Domain] Concentration Risk Type 2018 Flagship Agreement Two Thousand Eighteen Flagship Agreement [Member] 2018 flagship agreement member. Maturities of investments - marketable securities Maturities of Investments - Marketable Securitie Maturities of Investments - Marketable Securitie Antidilutive Securities, Name [Domain] Antidilutive Securities, Name Stockholders' Equity Note [Abstract] Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities, Total Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Statistical Measurement [Domain] Statistical Measurement Shares Representing Contingent Consideration Shares Representing Contingent Consideration Shares representing contingent consideration Contingently issuable common stock subject to vesting criteria Business Combination, Description [Abstract] Warrants exercise price Class of Warrant or Right, Exercise Price of Warrants or Rights Strike price Assets, Current Total current assets Share-Based Payment Arrangement, Expense Total stock-based compensation expense Stock-based compensation expense Period End Date Document Period End Date Forward Contract Indexed to Equity, Settlement, Share, Fair Value Fair value of stock Pre Funded Warrants [Member] Pre Funded Warrants [Member] Pre Funded Warrants [Member] Fair Value Hierarchy and NAV [Domain] Other programs Other Programs Expense Other Programs Expense ICFR Auditor Attestation Flag Number of Shares, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Contingently Issuable Common Shares Contingently Issuable Common Shares Contingently Issuable Common Shares Jefferies Agreement Jefferies Agreement [Member] Jefferies Agreement [Member] Series A-1 Warrants [Member] Series A-1 Warrants [Member] Series A-1 Warrants [Member] Effective Income Tax Rate Reconciliation, Tax Credit, Limitation on Tax Attributes, Amount Effective Income Tax Rate Reconciliation, Tax Credit, Limitation on Tax Attributes, Amount Limitation on tax attributes, Amount Statement of Financial Position [Abstract] Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Antidilutive Security, Excluded EPS Calculation [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Vesting [Axis] Vesting Class of Stock [Axis] Cybersecurity Risk Management, Strategy, and Governance [Line Items] Warrants, Maturity Date Warrants and Rights Outstanding, Maturity Date Liabilities Total liabilities Lessee, Operating Lease, Discount Rate Incremental Borrowing Rate Operating Costs and Expenses [Abstract] Costs and expenses: Financial Instruments [Domain] Revenue Recognition, Milestone Method [Table] Revenue Recognition Milestone Method [Table] Passthrough Costs Passthrough Costs Passthrough Costs Estimated Useful Lives Property, Plant and Equipment, Estimated Useful Life Property, Plant and Equipment, Estimated Useful Life Restricted Stock [Member] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Parkinson Disease Expense Parkinson Disease Expense Parkinson's disease Cash and Cash Equivalent [Table] Weighted Average Number of Shares Outstanding, Diluted Weighted-average number of common shares outstanding - diluted Weighted-average number of shares_diluted Entity File Number Cover Cover [Abstract] ATM Agreement [Member] ATM Agreement Member ATM Agreement Operating Loss With No Expiration Operating Loss With No Expiration Operating Loss With No Expiration Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Supplemental Balance Sheet Disclosures [Text Block] Supplemental Balance Sheet Information Revenue Benchmark [Member] Sales Revenue Scenario [Domain] US Treasury Securities [Member] U.S. treasury obligations [Member] Sale of Stock [Domain] Sale of Stock Non Cash IPR&D Acquired Through Common Stock Contingently Issued Shares Non Cash IPR&D Acquired Through Common Stock Contingently Issued Shares Non-cash IPR&D acquired through common stock contingently issued shares Segment Reporting Disclosure [Text Block] Segment Information Clinical Trial Supply Organization [Member] Clinical Trial Supply Organization [Member] Clinical Trial Supply Organization [Member] Series B Preferred Stock [Member] Series B Preferred Stock [Member] Deferred Tax Assets Capitalized Research And Development Deferred Tax Assets Capitalized Research And Development Capitalized research and development Accrued interest current. Accrued Interest Current Accrued interest Schedule Of Equipment and Improvements Table [Text Block] Schedule Of Equipment and Improvements Table [Text Block] Schedule Of Equipment and Improvements Subsequent Event [Table] Other Deferred Tax Assets, Other Issuance of common stock, pre-funded warrants and warrants, net of issuance costs, Shares Stock Issued During Period, Shares, Other Short-Term Debt, Type [Domain] Short-term Debt, Type Commitments Disclosure [Text Block] Commitments and Contingencies David McIntyre [Member] David McIntyre [Member] David McIntyre [Member] Operating Lease, Expense Operating Lease Expenses Marketable Securities [Abstract] Document Financial Statement Restatement Recovery Analysis [Flag] Weighted Average Exercise Price , Vested or Expected To Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price 2020 CEO Agreement Two Thousand Twenty CEO Employment Agreement [Member] 2020 ceo employment agreement member. Property, Plant and Equipment, Useful Life Estimated Useful Economical Life Short-Term Debt, Type [Axis] Short-term Debt, Type Recent Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Fair Value of Fully Vested Shares Fair Value of Fully Vested Shares Fair Value of Fully Vested Shares Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Other, Percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Share based compensation, vesting period Unrecognized Tax Benefits, Period Increase (Decrease) Unrecognized Tax Benefits, Period Increase (Decrease), Total Changes in Unrecognized Tax Benefits, Amount Effective Income Tax Rate Reconciliation, Amount [Abstract] Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] Depreciation, Total Depreciation Depreciation Performance Based Vesting Shares Performance Based Vesting Shares Performance based vesting shares Lessee, Operating Lease, Term of Contract Operating lease, term of contract Common Stock, Shares, Outstanding Ending balance, Shares Beginning balance, Shares Common stock, shares outstanding Operating Lease, Liability, Current Operating Lease Liability Current Technology Equipment [Member] IT equipment Summary of Future Principal Payments on Insurance Premium Financing Payable Contractual Obligation, Fiscal Year Maturity [Table Text Block] Cybersecurity Risk Management Processes Integrated [Flag] Document Transition Report Net deferred tax asset (liability) Deferred Tax Assets, Net Research and development expenses Research and Development Expense, Total Research and Development Expense Research and development Warrant Inducement Agreement [Member] Warrant Inducement Agreement [Member] Warrant Inducement Agreement [Member] Statement of Cash Flows [Abstract] Jefferies LLC [Member] Jefferies LLC [Member] Jefferies LLC Stock Issued During Period, Value, New Issues Issuance of common stock Share-Based Payment Arrangement, Option, Activity [Table Text Block] Summary of Option Activity Under 2011 Plan and 2020 Plan Change In Fair Value Contingent Consideration Change In Fair Value Contingent Consideration Change in fair value Change in fair value of contingent consideration Change in fair value contingent consideration H.C. Wainwright & Co., LLC [Member] H.C. Wainwright & Co., LLC [Member] H.C. Wainwright & Co., LLC Stock-based compensation, Percentage Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Equity [Text Block] Stockholders' Equity Earnings Per Share [Text Block] Net Loss Per Share Shares, Issued Shares issued Uncertain tax position impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Option Plan [Member] Option Plan [Member] Option Plan [Member] Computer Equipment [Member] Cybersecurity Risk Management Processes Integrated [Text Block] Sale of Stock, Consideration Received Per Transaction Sale of Stock, Consideration Received Per Transaction Net loss Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Capital Lease Obligation Capital Lease Obligation Lease obligation, net of current portion Warrants and Rights Outstanding, Term Contractual term Revenue Recognition, Milestone Method [Line Items] Revenue Recognition Milestone Method [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Research and development cost payable balance. Payable balance to vendor Research and Development Cost Payable Balance Assets [Abstract] Assets Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Weighted-average risk-free interest rate Increase (Decrease) in Prepaid Expense and Other Assets, Total Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Upfront Payment Received Upfront payment received Upfront payment Document Fiscal Year Focus Concentration Risk Benchmark [Domain] Concentration Risk Benchmark Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Cash flows from investing activities Retirement Benefits [Abstract] Accounts Payable, Current, Total Accounts Payable, Current Accounts payable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Fair Values of Stock Options, Vested, Total 2025 Lessor, Operating Lease, Payment to be Received, Year One Research and Development Expense [Member] Research and Development Defined Contribution Plan, Employer Matching Contribution, Percent of Match Individual retirement plan, percentage of qualified compensation match Components of Deferred Tax Assets [Abstract] Deferred tax assets: Issuance Costs Issuance Costs Issuance costs Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Issuance of common stock from exercise of stock options Proceeds from Stock Options Exercised Fair Value Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Seven U S Treasury Debt Securities [Member] Seven U S Treasury Debt Securities [Member] Seven U S Treasury Debt Securities Income Tax Credit Effective Income Tax Rate Reconciliation, Tax Credit, Amount Effective Income Tax Rate Reconciliation [Line Items] One U S Treasury Debt Securities [Member] One U S Treasury Debt Securities [Member] One U S Treasury Debt Securities [Member] Debt Instrument [Axis] Debt Instrument Share-Based Payment Arrangement [Abstract] Contingently Issuable Common Stock Subject To Vesting Criteria, Shares Contingently Issuable Common Stock Subject To Vesting Criteria, Shares Contingently Issuable Common Stock Subject To Vesting Criteria, Shares Sale of Stock [Axis] Sale of Stock Concentration Risk, Percentage Concentration risk, percentage Long-Term Debt and Lease Obligation, Current, Total Long-Term Debt and Lease Obligation, Current Lease obligation, current Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Private Placement [Member] Private Placement January 2023 Offering Title of 12(b) Security Schedule of Segment Reporting Information, by Segment [Table] License Agreement Term Description. License Agreement Term Description License agreement description Conversion of notes Warrants to purchase common stock Stock Issued During Period, Value, Conversion of Units Stock-based compensation, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price ,Forfeited Money Market Funds [Member] Money market funds Related and Nonrelated Parties [Domain] Income Tax Disclosure [Text Block] Income Tax Class of Warrant or Right [Line Items] Class Of Warrant Or Right [Line Items] Fixed commission percentage Fixed commission percentage Fixed commission percentage Lessor, Operating Lease, Payment to be Received Total lease payments Total lease payment CorHepta Transaction Costs CorHepta Transaction Costs CorHepta transaction costs Contingent Consideration [Member] Contingent Consideration [Member] Contingent consideration Noncash Accretion On Marketable Securities Noncash Accretion On Marketable Securities Non-cash accretion on marketable securities Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Share Price at Closing Business Combination, Price Per Share Property, Plant and Equipment [Table Text Block] Property and plant Estimated Useful Life Weighted Average Exercise Price, Outstanding Ending Balance Weighted Average Exercise Price, Outstanding Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Principal balance member. Principal Balance [Member] Principal Balance Accrued Professional Fees Consulting services fee accrued ATM program Text Block ATM program Text Block ATM Program Income Tax Disclosure [Abstract] Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Less: Accumulated Depreciation Business Combination [Text Block] Acquisition of CorHepta Additional Paid-in Capital [Member] Additional Paid-In Capital Stock Issued During Period, Value, Issued for Services License agreements, fair value of shares issued Measurement Frequency [Domain] Contract Research Organization [Member] Contract Research Organization [Member] Contract Research Organization [Member] Statement of Income Location, Balance [Axis] Income Statement Location Trading Symbol Property, Plant and Equipment Disclosure [Text Block] Equipment and Improvements 2020 CFO Agreement Two Thousand Twenty CFO Employment Agreement [Member] 2020 cfo employment agreement member. Subsequent Event Type [Axis] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash flows from financing activities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected terms Fair Value, Recurring [Member] Fair Value, Recurring Entity Ex Transition Period Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Less: imputed interest Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent R&D tax credits, Percentage Off Balance Sheet Risk And Concentrations Of Credit Risk [Policy Text Block] Off Balance Sheet Risk And Concentrations Of Credit Risk Policy [Text Block] Off-Balance Sheet Risk and Concentrations of Credit Risk Lexington [Member] Lexington [Member] Lexington Member Equity Components [Axis] Equity Components Warrants. Warrants [Text Block] Warrants Equity Component [Domain] Equity Component Pre Funded Warrants and Shares Held In Abeyance [Member] Pre Funded Warrants and Shares Held In Abeyance [Member] Pre Funded Warrants and Shares Held In Abeyance [Member] Deferred Tax Assets Deferred Tax Assets Fixed assets Schedule of allocation of consideration transferred Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block] Document Annual Report Business Combination [Axis] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Share based Compensation Arrangement By Share based Payment Award Unrecognized Compensation Cost Share based Compensation Arrangement By Share based Payment Award Unrecognized Compensation Cost Unrecognized Compensation Cost IPO IPO [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expected to Recognize, Remaining Weighted-Average Period Emory University License Agreements. Emory University License Agreements [Member] Emory University License Agreements US Treasury and Government [Member] U.S. Treasury obligations Maximum [Member] Maximum [Member] Statistical Measurement [Axis] Statistical Measurement Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price ,Exercised Prepaid Expense, Current, Total Prepaid Expense, Current Prepaid research and development Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Accrued expenses and other current liabilities Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Common stock, $0.001 par value; 500,000,000 and 100,000,000 shares authorized; 131,691,237 and 69,362,439 shares issued and outstanding (including 4,149,252 and 0 contingently issuable shares - see Note 7) at December 31, 2025 and December 31, 2024, respectively Consolidation, Policy [Policy Text Block] Consolidation Warrants and Rights Outstanding Fair value of warrant Equipment [Member] Lab equipment Deferred Tax Assets, Operating Loss Carryforwards, Total Deferred Tax Assets, Operating Loss Carryforwards Net operating loss carryforwards Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] Options to purchase shares of stock. Options To Purchase Shares Of Stock [Member] Options to Purchase Shares of Stock Cash and Cash Equivalents [Line Items] Production Related Impairments or Charges Production Related Impairments or Charges, Total Write-off of fully depreciated equipment and improvements Marketable Securities [Line Items] Marketable securities, available-for-sale: Capitalized Research And Development Expenses Capitalized Research And Development Expenses Capitalized Research And Development Expenses Offering costs underwriting discounts and commissions expenses. Offering Costs Underwriting Discounts And Commissions Expenses Offering costs, underwriting discounts and commissions Entity Public Float Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Preferred Stock, Shares Authorized Preferred stock, shares authorized Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition costs, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Acquisition costs, Amount Acquisition costs, Amount Costs and Expenses Total costs and expenses Summary of Insurance Premium Financing Payable Schedule of Debt [Table Text Block] Fair Value Of Restricted Stock Granted Fair Value Of Restricted Stock Granted Fair Value Of Restricted Stock Granted Business Combination [Table] Restricted common stock Restricted Common Stock [Member] Restricted Common Stock [Member] Registrant Name Entity Registrant Name Insurance Premium Financing Payable Debt Disclosure [Text Block] Entity Voluntary Filers Customer Concentration Risk [Member] Customer Concentration Risk Payments to Acquire in Process Research and Development Acquired in-process research and development Contingent Consideration Liabilities Business Combination, Contingent Consideration [Table Text Block] Series D Preferred Stock [Member] Series D Preferred Stock [Member] Subsequent Events [Abstract] First Dosing of Patient In U S Phase1 Trial First Dosing Of Patient In US Phase 1 Trial. First Dosing Of Patient In U S Phase1 Trial [Member] Cybersecurity Risk Management Positions or Committees Responsible [Flag] Income Tax Expense (Benefit) Provision or benefit for income tax Total Income Tax Expense (Benefit), Amount Measurement Frequency [Axis] Number Of License Agreements. Number Of License Agreements Number of license agreements Income taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Proceeds from issuance of common stock, pre-funded warrants and warrants, net of issuance costs Proceeds from Issuance of Common Stock Aggregate gross sales price amount Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Series B-1 Warrants [Member] Series B-1 Warrants [Member] Series B-1 Warrants [Member] Non-cash financing costs included in Accounts payable Non-Cash Financing Costs Included in Accounts Payable Non-Cash Financing Costs Included in Accounts Payable Entity Common Stock, Shares Outstanding Compensation Related Costs, Policy [Policy Text Block] Stock-Based Compensation Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) Consolidation Items [Axis] Warrants Exercised Warrants Exercised CEO note. C E O Note [Member] CEO Note Offering Offering [Member] Offering member. Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Purchases of equipment and improvements Purchases of equipment and improvements Assets Total assets Property, Plant and Equipment [Table] Weighted Average Remaining Contractual Term (In Years), Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Income Statement [Abstract] Other Selling, General and Administrative Expense Selling, general and administrative (excluding stock-based compensation) Cash, Cash Equivalent, and Marketable Security [Text Block] Marketable Securities Legal Fees Legal Expenses Selling, General and Administrative Expenses [Member] Selling, General and Administrative Number of Shares Sold Sale of Stock, Number of Shares Issued in Transaction Number of common stock sold Stock Issued During Period, Shares, New Issues Issuance of common stock, Shares Business Combination [Abstract] Earnings Per Share, Diluted Net loss per share applicable to common stockholders - diluted Net loss per share - diluted Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of financial information regularly reviewed and used by the CODM Effective Income Tax Rate Reconciliation, Percent [Abstract] Asset Acquisition [Axis] City Area Code Sphaera Agreement. Sphaera Agreement [Member] Sphaera Agreement Other Comprehensive Income (Loss), Net of Tax Comprehensive loss Comprehensive loss Auditor Name Debt Instrument, Face Amount Debt Instrument, Face Amount Business Combination [Line Items] Service Based Vesting Shares Service Based Vesting Shares Service based vesting shares Income taxes table Income Taxes [Table] Income Taxes [Table] Defined Benefit Plan [Table] Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount R&D tax credits, Amount R&D tax credits, Amount Segment Reporting Information [Line Items] Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split ratio Stock Issued During Period, Shares, Restricted Stock Award, Gross Restricted share issued Lease Expiration Date Lease Expiration Date Award Date [Axis] Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents and Marketable Securities Property, Plant and Equipment, Net, Total Property, Plant and Equipment, Net Equipment and improvements, net Asset Acquisition, Contingent Consideration, Liability Additions Additions Asset Acquisition, Contingent Consideration, Liability Additions Operating Income (Loss) Loss from operations Loss from operations Award Date [Domain] November Two Thousand Twenty Five Offering [Member] November Two Thousand Twenty Five Offering [Member] November 2025 Offering [Member] Retained Earnings [Member] Accumulated Deficit Cash and Cash Equivalents [Axis] Share-based Payment Arrangement, Noncash Expense, Total Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Performance Commitment, Milestones Performance Commitment, Milestones Performance milestones In Process Research And Development In Process Research And Development In Process Research And Development US Phase 1 Trial Completion with Endpoints Met US Phase 1 Trial Completion With Endpoints Met. U S Phase1 Trial Completion With Endpoints Met [Member] Operating Lease, Liability, Noncurrent Operating Lease Liability Non current Fair Value, Inputs, Level 1 [Member] Level 1 Class Of Stock [Line Items] Class of Stock [Line Items] Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Insurance premium financing payable Notes payable outstanding Notes Payable, Total Notes Payable Shares Vested on Acquisition Shares Vested on Acquisition Shares vested Active Grant Grants Receivable Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent [Abstract] Nontaxable or Nondeductible Items: Auditor Location Marketable Securities [Table Text Block] Summary of Marketable securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Summary of Shares Excluded from Calculation of Diluted Net Loss per Share Applicable to Common Stockholders Income Tax Jurisdiction [Domain] Income Tax Authority Entity Interactive Data Current Short-Term Lease Payments Short term lease payments Statement of Income Location, Balance [Domain] Income Statement Location Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash flows from operating activities Furniture and Fixtures [Member] Furniture and office equipment Weighted Average Remaining Contractual Term (In Years), Granted Share-based Payment Award Options, Granted, Weighted Average Remaining Contractual Term. Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term Segment Reporting Information, Revenue for Reportable Segment [Abstract] Revenues and other income 2014 CEO Agreement Two Thousand Fourteen Ceo Agreement [Member] 2014 CEO agreement member. Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Shares issued in exchange for consulting services Stock Issued During Period, Shares, Issued for Services License agreements, shares issued US Phase 2 Trial Completion with Endpoints Met US Phase 1 Trial Completion With Endpoints Met. U S Phase2 Trial Completion With Endpoints Met [Member] Pulmonary Arterial Hypertension Expense Pulmonary Arterial Hypertension Expense PAH Entity Tax Identification Number Contingent Consideration Liability Contingent Consideration Liability Contingent consideration liability Balance, beginning Balance, ending Schedule of accrued expenses and other current liabilities. Schedule Of Accrued Expenses And Other Current Liabilities Table [Text Block] Schedule of accrued expenses and other current liabilitiies Marketable Security, Unrealized Gain (Loss) Unrealized gain (loss) on marketable securities Unrealized gain (loss) on marketable securities Increase Decrease In Operating Lease Right Of Use Assets Increase Decrease In Operating Lease Right Of Use Assets Operating lease right of use assets Pre-Funded Warrant [Member] pre-funded Warrant [Member] Pre-Funded Warrant [Member] Schedule of Fair Value of Consideration Transferred [Table Text Block] Schedule of Fair Value of Consideration Transferred [Table Text Block] Schedule of fair value of consideration transferred Series of Individually Immaterial Asset Acquisitions [Member] Series of Individually Immaterial Asset Acquisitions Local Phone Number Related Party Transaction [Domain] Debt Securities, Available-for-Sale, Unrealized Gain Marketable securities, Unrealized Gain Debt Securities, Realized Gain (Loss) Marketable securities, Unrealized Loss Marketable securities, Unrealized Loss Marketable securities, Unrealized Gain Unrecognized stock-based compensation of unvested options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Auditor Opinion [Text Block] Auditor Opinion Accounting Policies [Abstract] Common Warrants [Member] Common Warrants [Member] Common Warrants [Member] Clinical Trial Supply Services Clinical Trial Supply Services Amount of clinical trial supply Total revenue Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Grant income Fifth restated note. Fifth Restated Note [Member] Fifth Restated Note Net Income (Loss) Attributable to Parent [Abstract] Numerator: Class of Stock [Domain] Number of shares available for grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Office Equipment [Member] Furniture and office equipment Accrued Professional Fees, Current Accrued legal and professional fees Stock, Class of Stock [Table] Schedule Of Stock By Class [Table] Amortisation Of Research And Developmental Cost Amortisation Of Research And Developmental Cost Amortisation Of Research And Developmental Cost Entity Emerging Growth Company Weighted Average Remaining Contractual Term (In Years), Vested and Expected To Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Indefinite-Lived Intangible Assets [Axis]